ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Down 14.6% – Time to Sell?

ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report)’s share price was down 14.6% on Wednesday. The company traded as low as $8.18 and last traded at $8.32. 141,074 shares changed hands during mid-day trading, a decline of 36% from the average daily volume of 219,053 shares. The stock had previously closed at $9.74.

Analyst Upgrades and Downgrades

CHRN has been the topic of several recent research reports. Northland Securities started coverage on shares of ChronoScale Corporation Common Stock in a research report on Friday, September 18th. They set an “outperform” rating and a $32.00 price target on the stock. Compass Point assumed coverage on shares of ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 price target on the stock. Finally, Weiss Ratings cut shares of ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research note on Friday, October 23rd. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, ChronoScale Corporation Common Stock presently has a consensus rating of “Hold” and a consensus price target of $28.50.

Read Our Latest Research Report on CHRN

ChronoScale Corporation Common Stock Stock Down 7.4%

The firm has a market cap of $1.31 billion, a P/E ratio of -2.09 and a beta of 1.12. The firm’s fifty day moving average is $16.39 and its 200 day moving average is $16.14. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30.

ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) last issued its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. The company had revenue of $41.48 million for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. As a group, equities research analysts anticipate that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current fiscal year.

ChronoScale Corporation Common Stock Company Profile

(Get Free Report)

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

See Also

Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.